Molecular imaging with targeted contrast agents and high frequency ultrasound

被引：4

作者：

van Wamel, Annemieke ^{[1
]}

Celebi, Muzaffer ^{[2
]}

Hossack, John A. ^{[3
]}

Backer, Joseph M. ^{[4
]}

Backer, Marina V. ^{[4
]}

Ley, Klaus ^{[3
,5
]}

de Jong, Nico ^{[1
]}

Klibanov, Alexander L. ^{[2
,3
,5
]}

机构：

[1] Erasmus MC, Biomed Engn, Rotterdam, Netherlands

[2] Univ Virginia, Cardiovascular Div, Charlottesville, VA USA

[3] Univ Virginia, Biomed Engn, Charlottesville, VA USA

[4] Sibtech Inc, Newington, CT USA

[5] Univ Virginia, Robert M Berne Cardiovascular Res Ctr, Charlottesville, VA USA

来源：

2007 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1-6 | 2007年

关键词：

component; high frequency ultrasound; molecular imaging; contrast agents; tumor;

D O I：

10.1109/ULTSYM.2007.245

中图分类号：

O42 [声学];

学科分类号：

070206 ; 082403 ;

摘要：

Targeted ultrasound contrast agents (USCA) can be used as molecular imaging agents to visualize the expression of endothelial molecules (biomarkers). in a murine tumor model, three biomarkers for tumor vasculature were imaged using targeted USCA and the high frequency ultrasound system Vevo 770. Three biomarkers were targeted: VCAM-1, selectins (P and E), and VEGF receptors. Targeting was determined by ultrasound contrast imaging of the adhered 2 USCA in tumors ranging in size from 3 up to 40 mm. Dependent on the tumor size, targeting of ultrasound contrast agents to the tumor vasculature resulted in significant signal enhancement when compared to control contrast agent. Each targeted contrast agent had it own accumulation level during tumor growth indicating differential expression pattern of the investigated target molecules during tumor growth. High frequency imaging with targeted ultrasound contrast can provide dynamic and quantitative information about the molecular profile of the tumor vasculature. This can open the possibility for patient-tailored therapy and can provide a tool to monitor whether the therapy is having the desired effect.

引用

页码：961 / +

页数：3

共 50 条

[1] Molecular imaging with targeted ultrasound contrast agents
Lanza, G
Hall, C
Scott, M
Fuhrhop, R
Marsh, J
Wickline, S
[J]. 2000 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1 AND 2, 2000, : 1917 - 1926
[2] Targeted ultrasound contrast agents for ultrasound molecular imaging and therapy
van Rooij, Tom
Daeichin, Verya
Skachkov, Ilya
de Jong, Nico
Kooiman, Klazina
[J]. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2015, 31 (02) : 90 - 106
[3] Ultrasound molecular imaging with targeted microbubble contrast agents
Alexander L. Klibanov
[J]. Journal of Nuclear Cardiology, 2007, 14
[4] Ultrasound molecular imaging by targeted microbubble contrast agents
Mancini, M.
Greco, A.
Speranza, A.
Salvatore, M.
[J]. MINERVA BIOTECNOLOGICA, 2009, 21 (02) : 97 - 110
[5] Ultrasound molecular imaging with targeted microbubble contrast agents
Klibanov, Alexander L.
[J]. JOURNAL OF NUCLEAR CARDIOLOGY, 2007, 14 (06) : 876 - 884
[6] Targeted microbubbles: ultrasound contrast agents for molecular imaging
Du, Z.
Unnikrishnan, S.
Smith, D.
Rychak, J. J.
Klibanov, A. L.
[J]. JOURNAL OF NUCLEAR MEDICINE, 2013, 54 : 32 - 32
[7] Preparation of targeted microbubbles: ultrasound contrast agents for molecular imaging
Klibanov, Alexander L.
[J]. MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 2009, 47 (08) : 875 - 882
[8] Preparation of targeted microbubbles: ultrasound contrast agents for molecular imaging
Alexander L. Klibanov
[J]. Medical & Biological Engineering & Computing, 2009, 47 : 875 - 882
[9] Advancement of Targeted Ultrasound Contrast Agents and their Applications in Molecular Imaging and Targeted Therapy
Yang, Feng
Chen, Zhi-Yi
Lin, Yan
[J]. CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (08) : 1516 - 1527
[10] Molecular Imaging with Targeted Contrast Ultrasound
Piedra, Mark
Allroggen, Achim
Lindner, Jonathan R.
[J]. CEREBROVASCULAR DISEASES, 2009, 27 (SUPPL 2) : 66 - 74

← 1 2 3 4 5 →